Unlike currently available GLP-1 drugs (glucagon-like peptide 1) including semaglutide, sold as Ozempic and Wegovy, aleniglipron is a small-molecule drug that is taken orally and is currently in development for the treatment of obesity
Polonsky, PhD, CDCES (Behavioral Diabetes Institute) Co-Investigators: N/A Collaborators: Susan Guzman, PhD (Behavioral Diabetes Institute) & Martha Funnell, MS, RN, CDE, FAAN (University of Michigan) Community Partners: N/A Funder: Abbott Diabetes Care Status: COMPLETED /2021-2022 ClinicalTrials.gov link: N/A Related Publications and Presentations: Polonsky WH, Fortmann AL
From the moment you walk through our doors for your initial consultation, to each follow-up appointment, we guide and support you through a tailored treatment process designed for your success
Learn More Workplace Accidents Workplace Accidents Dealing with a workers compensation insurance company can be incredibly stressful
Conversely, individuals who live to 100 tend to have higher glutathione activity